{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:18:23Z","timestamp":1781198303924,"version":"3.54.1"},"reference-count":30,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["RMHP"],"DOI":"10.2147\/rmhp.s577383","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T13:00:18Z","timestamp":1770123618000},"page":"1-9","source":"Crossref","is-referenced-by-count":1,"title":["Policy Evaluation for Regulating Toxic Traditional Chinese Medicines in Taiwan"],"prefix":"10.2147","volume":"Volume 19","author":[{"given":"Yi-Shan","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Hsun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8918-2618","authenticated-orcid":true,"given":"Yu-Pei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.6288\/TJPH.201912_38(6).108104","volume":"38","author":"Chen","year":"2019","journal-title":"Taiwan J Public Health"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3969\/j.issn.1004-3594.2017.08.027","volume":"28","author":"Li","year":"2017","journal-title":"Med J Chin People\u2019s Armed Police Forces"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3969\/j.issn.1002-2406.2002.05.011","volume":"19","author":"Zhang","year":"2002","journal-title":"Inf Tradit Chin Med"},{"key":"ref4","unstructured":"Ministry of Health and Welfare. Department of Chinese Medicine and Pharmacy. Prohibition on the manufacture, dispensing, import, export, sale, or display of Chinese medicine containing cinnabar effective. Taipei: Ministry of Health and Welfare. Available from: https:\/\/dep.mohw.gov.tw\/DOCMAP\/cp-752-5304-108.html. Accessed September 26, 2025."},{"key":"ref5","unstructured":"Ministry of Health and Welfare. Department of Chinese Medicine and Pharmacy. Prohibition on the use of five Chinese medicinal materials including Aristolochia, Qingmuxiang, Guanmutong, Madouling, and Tianxianteng. Taipei: Ministry of Health and Welfare. Available from: https:\/\/dep.mohw.gov.tw\/DOCMAP\/cp-752-5315-108.html. Accessed September 26, 2025."},{"key":"ref6","unstructured":"Ministry of Health and Welfare. Taiwan Pharmacopoeia. Taipei: Ministry of Health and Welfare; 2021: Available from: https:\/\/dep.mohw.gov.tw\/DOCMAP\/lp-759-108.html. Accessed September 26, 2025."},{"key":"ref7","volume-title":"The Researches and Literary Reviews of Aristolochiaceae Herbs","year":"2005"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0140-6736(93)92984-2","volume":"341","author":"Vanherweghem","year":"1993","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1089\/acm.1998.4.1-9","volume":"4","author":"Vanherweghem","year":"1998","journal-title":"J Altern Complement Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0140-6736(99)03380-2","volume":"354","author":"Lord","year":"1999","journal-title":"Lancet"},{"key":"ref11","unstructured":"Lan YS. Application of risk assessment on aristolochic acids in Chinese herbal medicine Asarum \u2013 a study of medication safety of traditional Chinese medicine in Taiwan [master\u2019s thesis]. Tainan: National Cheng Kung University; 2021."},{"key":"ref12","unstructured":"Ministry of Health and Welfare. Department of Chinese Medicine and Pharmacy. Withdrawal of marketing authorizations for aristolochic acid-containing products. Taipei: Ministry of Health and Welfare. Available from: https:\/\/dep.mohw.gov.tw\/DOCMAP\/cp-862-5442-108.html. Accessed January 30, 2025."},{"key":"ref13","unstructured":"National Medical Products Administration. Pharmacopoeia of the People\u2019s Republic of China. Beijing: National Medical Products Administration; 2020. Available from: https:\/\/ydz.chp.org.cn\/#\/main. Accessed September 26, 2025."},{"key":"ref14","unstructured":"Pharmaceutical Services Programme, Ministry of Health Malaysia. Poisons Act 1952 and Regulations. Putrajaya: Ministry of Health Malaysia. Available from: https:\/\/pharmacy.moh.gov.my\/en\/documents\/poisons-act-1952-and-regulations.html. Accessed September 26, 2025."},{"key":"ref15","unstructured":"Health Sciences Authority, Therapeutic Products Branch. Guidelines for the application for approval of Chinese proprietary medicines. Singapore: Health Sciences Authority; 2024 Nov. p. 9\u201310 Available from: https:\/\/www.hsa.gov.sg\/docs\/default-source\/hprg-tmhs\/chinese-proprietary-medicines\/pl_fsc_guidelines_chi.pdf. Accessed September 26, 2025."},{"key":"ref16","unstructured":"Department of Chinese Medicine and Pharmacy, Ministry of Health and Welfare. Regulations on the management of Asarum herb and its preparations, effective from the date of announcement. Taipei: Ministry of Health and Welfare. Available from: https:\/\/dep.mohw.gov.tw\/DOCMAP\/cp-752-7105-108.html. Accessed September 26, 2025."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6288\/TJPH2007-26-01-01","volume":"26","author":"Li","year":"2007","journal-title":"Taiwan J Public Health"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3966\/101764462014122502014","volume":"25","author":"Huang","year":"2014","journal-title":"J Chin Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jep.2012.12.027","volume":"146","author":"Kim","year":"2013","journal-title":"J Ethnopharmacol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.30018\/JECCM.199706.0004","volume":"8","author":"Chen","year":"1997","journal-title":"J Emerg Crit Care Med"},{"key":"ref21","volume-title":"Science of Chinese Herbal Processing","year":"2003"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jep.2013.01.025","volume":"146","author":"Tong","year":"2013","journal-title":"J Ethnopharmacol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.6516\/TJTCM.2017.20(1)103","volume":"20","author":"Chen","year":"2017","journal-title":"Taipei J Tradit Chin Med"},{"key":"ref24","first-page":"58","volume":"39","author":"Chen","year":"2017","journal-title":"Hubei J Tradit Chin Med"},{"key":"ref25","unstructured":"National Medical Products Administration. Central People\u2019s Government of the People\u2019s Republic of China. Announcement on the issuance of special provisions for the management of Chinese medicine standards. Beijing: National Medical Products Administration. Available from: https:\/\/www.gov.cn\/zhengce\/zhengceku\/202407\/content_6962491.htm. Accessed September 26, 2025."},{"key":"ref26","unstructured":"National Health Commission of the People\u2019s Republic of China. Regulations on the management of toxic drugs for medical use. Beijing: National Health Commission; 1988. Available from: https:\/\/www.nhc.gov.cn\/fzs\/c100048\/201808\/6effc859f8e54336b9b8560fa8de5386.shtml. Accessed September 26, 2025."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3969\/j.issn.1006-4931.2000.01.059","volume":"9","author":"Ho","year":"2000","journal-title":"China Pharm"},{"key":"ref28","unstructured":"Health Sciences Authority. Regulatory overview of Chinese Proprietary Medicines. Singapore: Health Sciences Authority. Available from: https:\/\/www.hsa.gov.sg\/chinese-proprietary-medicines\/overview. Accessed September 26, 2025."},{"key":"ref29","unstructured":"Taiwan Food and Drug Administration, Ministry of Health and Welfare. National Adverse Drug Reaction Reporting System. Taipei: Taiwan Food and Drug Administration. Available from:: https:\/\/adr.fda.gov.tw\/Manager\/WebLogin.aspx. Accessed September 26, 2025."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.30031\/JCMHD.201002.0008","volume":"6","author":"Yu","year":"2010","journal-title":"J Chin Med Hepat Dis"}],"container-title":["Risk Management and Healthcare Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/111628","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/111628","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T13:00:25Z","timestamp":1770123625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/policy-evaluation-for-regulating-toxic-traditional-chinese-medicines-i-peer-reviewed-fulltext-article-RMHP"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":30,"URL":"https:\/\/doi.org\/10.2147\/rmhp.s577383","relation":{},"ISSN":["1179-1594"],"issn-type":[{"value":"1179-1594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}